One of the potential markers of stage 1 non-small cell lung cancer is the lncRNA MALAT1, which can be significantly down-regulated after resveratrol treatment, suggesting that resveratrol may be an entry point for the treatment of non-small cell carcinoma (136). Here, MALAT1 is linked to non-small cell lung carcinoma.